Short description
Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.
Description
Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly "search and replace" to restore normal genetic function and address the fundamental causes of disease.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2019
Exited on
October 20, 2022
Went public on
October 20, 2022
Stock symbol
PRME
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh, No Way, Uh Ohhhh, Noway Youcantaccess, Blurry Noaccess, Noaccess, Noway Youcantaccess, Blurry Noaccess, No Way, Uh Ohhhh, Cannot Access, Uh Ohhhh, Noaccess
Sign in for full access
Founders
Andrew Anzalone, David R. Liu